143 related articles for article (PubMed ID: 38725620)
1. Prognostic analysis of stage IIIC1p cervical cancer patients.
Gao T; Yang Z; Wei L; Tang X; Ma S; Jiang L; Zhang Y; Wu F
Front Oncol; 2024; 14():1362281. PubMed ID: 38725620
[TBL] [Abstract][Full Text] [Related]
2. Prognostic analysis of patients with stage IIIC1p cervical cancer treated by surgery.
Fan X; Wang Y; Yang N; Zhu P
World J Surg Oncol; 2023 Jun; 21(1):186. PubMed ID: 37344912
[TBL] [Abstract][Full Text] [Related]
3. Risk Stratification Based on Metastatic Pelvic Lymph Node Status in Stage IIIC1p Cervical Cancer.
Li A; Wang L; Jiang Q; Wu W; Huang B; Zhu H
Cancer Manag Res; 2020; 12():6431-6439. PubMed ID: 32801883
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive analysis of the factors of positive pelvic lymph nodes on survival of cervical cancer patients with 2018 FIGO stage IIIC1p.
Yan DD; Tang Q; Tu YQ; Chen JH; Lv XJ
Cancer Manag Res; 2019; 11():4223-4230. PubMed ID: 31123422
[No Abstract] [Full Text] [Related]
5. Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
Liu J; Tang G; Zhou Q; Kuang W
Radiat Oncol; 2022 Aug; 17(1):142. PubMed ID: 35978412
[TBL] [Abstract][Full Text] [Related]
6. [Outcomes and prognosis of radical surgery in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma].
Zhou F; Chen F; Pan T; Zhu T; Zhang YL; Zhang P; Tang HR
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):361-369. PubMed ID: 35658327
[No Abstract] [Full Text] [Related]
7. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
[TBL] [Abstract][Full Text] [Related]
8. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
Ma R; Zhang H; Zou L; Qu Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological risk factors in the light of the revised 2018 International Federation of Gynecology and Obstetrics staging system for early cervical cancer with staging IB: A single center retrospective study.
Zeng J; Qu P; Hu Y; Sun P; Qi J; Zhao G; Gao Y
Medicine (Baltimore); 2020 Apr; 99(16):e19714. PubMed ID: 32311956
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes and Prognostic Factors in Stage III C Cervical Cancer Patients Treated with Radical Radiotherapy or Radiochemotherapy.
Zhang W; Yu H; Xiu Y; Meng F; Wang Z; Zhao K; Wang Y; Chen Z; Liu J; Chen J; Sun B
Technol Cancer Res Treat; 2024; 23():15330338241254075. PubMed ID: 38720626
[No Abstract] [Full Text] [Related]
11. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
[TBL] [Abstract][Full Text] [Related]
12. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
[TBL] [Abstract][Full Text] [Related]
13. [Curative effect analysis of postoperative concurrent chemoradiotherapy on early-stage cervical cancer patients with intermediate-risk factors].
Tang Q; Tu YQ; Chen JH; Lyu XJ; Yan DD
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):462-466. PubMed ID: 29936774
[No Abstract] [Full Text] [Related]
14. Prognostic evaluation of postoperative adjuvant therapy for operable cervical cancer: 10 years' experience of National Cancer Center in China.
Shu T; Zhao D; Li B; Wang Y; Liu S; Li P; Zuo J; Bai P; Zhang R; Wu L
Chin J Cancer Res; 2017 Dec; 29(6):510-520. PubMed ID: 29353973
[TBL] [Abstract][Full Text] [Related]
15. Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery.
Zhang X; Lv Z; Xu X; Yin Z; Lou H
BMC Cancer; 2020 Jul; 20(1):664. PubMed ID: 32678039
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
[TBL] [Abstract][Full Text] [Related]
17. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.
Kubota H; Tsujino K; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Soejima T; Yamaguchi S; Sasaki R
Radiat Oncol; 2019 Dec; 14(1):236. PubMed ID: 31878944
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the 2018 FIGO staging system for cervical cancer patients with surgical risk factors.
Yan DD; Tang Q; Chen JH; Tu YQ; Lv XJ
Cancer Manag Res; 2019; 11():5473-5480. PubMed ID: 31354353
[No Abstract] [Full Text] [Related]
19. Populational trends and outcomes of postoperative radiotherapy for high-risk early-stage cervical cancer with lymph node metastasis: concurrent chemo-radiotherapy versus radiotherapy alone.
Matsuo K; Nusbaum DJ; Machida H; Huang Y; Khetan V; Matsuzaki S; Klar M; Grubbs BH; Roman LD; Wright JD
Am J Obstet Gynecol; 2020 May; 222(5):484.e1-484.e15. PubMed ID: 31678092
[TBL] [Abstract][Full Text] [Related]
20. [Effects of colpotomic approaches on prognosis and recurrence sites of stage Ⅰa2-Ⅱa2 cervical cancer after laparoscopic radical hysterectomy].
Zhou D; Li YD; Ling KJ; Wang RW; Wang YZ; Tang S; Liang ZQ
Zhonghua Fu Chan Ke Za Zhi; 2023 Jan; 58(1):49-59. PubMed ID: 36720615
[No Abstract] [Full Text] [Related]
[Next] [New Search]